Focuses on Volatile Stocks ( CRY, MGLN, KEX, VAR )

Los Angelas, CA -- (SBWIRE) -- 10/31/2012 -- CryoLife, Inc. (NYSE:CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today its results for the third quarter and first nine months of 2012. Revenues for the third quarter of 2012 increased 13 percent to a record $33.4 million compared to $29.7 million for the third quarter of 2011. Revenues for the first nine months of 2012 increased 11 percent to a record $98.9 million compared to $89.2 million for the first nine months of 2011. CryoLife, Inc. Co (NYSE:CRY) is +0.32 - +5.48% from the previous close of $5.84. It traded between $5.82 - 6.26 with total traded volume of 117677 shares. At Current Market Price, CRY is in distance of +0.47% from its 50-day Moving Average price of $6.1311 and +15.24% from its 200-day Moving Average price of $5.3454. CryoLife (NYSE: CRY) posted its quarterly earnings results on Tuesday. The company reported $0.08 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.04 by $0.04. The company had revenue of $33.40 million for the quarter, compared to the consensus estimate of $32.45 million. CryoLife’s revenue was up 12.5% compared to the same quarter last year.

How Should Investors Trade CRY Now? Find Out Here

Magellan Health S (NasdaqNM:MGLN) are trading at $50.69 and is +0.91% from its 50-day Moving Average price of $50.2311 and +7.62% from its 200-day Moving Average price of $47.1011. The average trading volume is 251623 shares and its market capitalization is $1.387B. Equities research analysts at Goldman Sachs increased their price target on shares of Magellan Health Services (NASDAQ: MGLN) from $46.00 to $51.00 in a research note issued to investors on Monday. The firm currently has a “sell” rating on the stock. The analysts wrote, “3Q earnings upside was primarily driven by margin expansion as Magellan benefitted from favorable cost trends in the behavioral health segment. Management sees “solid” segment profit growth for next year relative to a 2012 baseline of $240-$245 mn, which excludes prior year developments. [W]e now see somewhat lower procurement risk to the company’s Maricopa behavioral health contract, as detail from the recently released RFP (worth $1 bn in annual revenue, including physical health) suggests that Magellan’s joint venture with Vanguard Health Systems should not be at any disadvantage in the bidding process.”

Get A Free Analysis Report On MGLN : CLICK HERE

Kirby Corporation (NYSE:KEX) is +2.95 - +5.35% from the previous close of $55.18. It traded between $56.35 - 58.24 with total traded volume of 905846 shares. At Current Market Price, KEX is in distance of +1.68% from its 50-day Moving Average price of $57.1714 and +5.18% from its 200-day Moving Average price of $55.2653. U.S. barge operator Kirby Corp. (Kirby) [NYSE:KEX] said its earnings per share rose to 95 cents in the third quarter of 2012, up from 94 cents in the same period last year, despite a 3 to 4 cent negative impact from low water and Hurricane Isaac. "We were pleased with our overall third quarter performance, particularly in light of challenging weather conditions related to persistent low water throughout the Mississippi River System and the impact of Hurricane Isaac," said Joe Pyne, Kirby's chairman and CEO. The company's average cost of fuel consumed fell 5.2 percent year-on-year to $3.10 per gallon from $3.27 per gallon for the third quarter of 2011. Profits for the three months ended September 30, 2012 totaled $53.1 million on revenues of $521.3 million, compared with profits of $52.7 million and revenues of $563.6 million in Q3 2011.

How Should Investor Trade KEX Now : CHECK HERE

Varian Medical Sy (NYSE:VAR) reported EPS of 3.76. For the Current Fiscal year, the company is expected to report EPS of 4.11. For the Next Quarter and Next Year, the company is expected to report EPS of 1.03 and 4.55 respectively. At Current Market Price, VAR is in distance of +11.25% from its 50-day Moving Average price of $60.1633 and +10.86% from its 200-day Moving Average price of $60.3731. Varian Medical Systems, Inc. (NYSE: VAR) medical equipment provider announced fiscal fourth-quarter on 25 Oct, after earnings announcement company gained a massive gain as earnings for the fourth quarter jumped 19%. Varian Medical Systems, Inc. (NYSE: VAR) beaten analysts estimations for the quarter. On October 26, next day of earning announcement Varian Medical Systems, Inc. (NYSE: VAR) gained more than double volume in shares. Investors are watching at the stock that either it will continue its massive gain, as after earning announcement VAR reporting more than double volume in shares regularly.

Is VAR will continue moving higher? Find out where VAR is headed next with a FREE TREND ANALYSIS REPORT

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com